Table 1 Multivariate analysis: breast and bowel screening uptakes by age group and gender

50–54

17453

77.13

1 (-)

55–59

20307

76.63

0.97⁺ (0.92, 1.02)

Breast screening

60–64

20081

72.16

0.78** (0.74, 0.82)

Round 1: 1989–92

65–69

4051

68.28

0.65** (0.60, 0.71)

50–54

19176

78.99

1 (-)

55–59

20894

78.15

0.96⁺ (0.91, 1.01)

Breast screening

60–64

19144

74.68

0.79** (0.75, 0.83)

Round 2: 1992–95

65–69

3577

69.33

0.61** (0.56, 0.67)

50–54

26909

78.71

1 (-)

55–59

26175

78.93

1.00⁺ (0.96, 1.04)

Breast screening

60–64

19733

76.93

0.91** (0.87, 0.95)

Round 5: 2001–04

65–69

13394

73.32

0.75** (0.71, 0.79)

50 – 54

36832

54.74

1 (-)

55 – 59

34931

29.30

1.18** (1.15, 1.22)

Bowel screening

60 – 64

27518

62.58

1.41** (1.36, 1.45)

Round 1: 2000–02

65 – 69

23968

64.86

1.56** (1.51, 1.61)

50 – 54

32426

47.44

1 (-)

55 – 59

34309

52.88

1.21** (1.17, 1.24)

Bowel screening

60 – 64

27336

57.69

1.49** (1.44, 1.54)

Round 2: 2003–05

65 – 69

22588

61.44

1.77** (1.71, 1.84)

Cancer screening Programme/Round

Gender

Number

Uptake (%)

Adjusted OR (95% CI)

Bowel screening

Male

61650

55.30

1 (-)

Round 1: 2000–02

Female

61599

64.21

1.46** (1.43, 1.50)

Bowel screening

Male

58395

50.08

1 (-)

Round 2: 2003–05

Female

58264

58.21

1.39** (1.36, 1.43)